Details
Stereochemistry | RACEMIC |
Molecular Formula | C17H27N |
Molecular Weight | 245.403 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)CCC(C1CCCCC1)C2=CC=CC=C2
InChI
InChIKey=AJDSHXKJJDQZCJ-UHFFFAOYSA-N
InChI=1S/C17H27N/c1-18(2)14-13-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16/h3,5-6,9-10,16-17H,4,7-8,11-14H2,1-2H3
Molecular Formula | C17H27N |
Molecular Weight | 245.403 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
DescriptionSources: https://pubchem.ncbi.nlm.nih.gov/compound/Gamfexine |
https://en.wikipedia.org/wiki/GamfexineCurator's Comment: 3 Pubmed ID's, but are title only
Sources: https://pubchem.ncbi.nlm.nih.gov/compound/Gamfexine |
https://en.wikipedia.org/wiki/Gamfexine
Curator's Comment: 3 Pubmed ID's, but are title only
Gamfexine (WIN 1344) was introduced in the literature in 1966 as an anti-depressant. Although it was reported to be effective in the treatment of withdrawal in schizophrenia, it worsened psychotic symptoms.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:46:56 GMT 2023
by
admin
on
Fri Dec 15 16:46:56 GMT 2023
|
Record UNII |
3U2V80KPAL
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C166697
Created by
admin on Fri Dec 15 16:46:56 GMT 2023 , Edited by admin on Fri Dec 15 16:46:56 GMT 2023
|
PRIMARY | |||
|
SUB07878MIG
Created by
admin on Fri Dec 15 16:46:56 GMT 2023 , Edited by admin on Fri Dec 15 16:46:56 GMT 2023
|
PRIMARY | |||
|
2225
Created by
admin on Fri Dec 15 16:46:56 GMT 2023 , Edited by admin on Fri Dec 15 16:46:56 GMT 2023
|
PRIMARY | |||
|
3U2V80KPAL
Created by
admin on Fri Dec 15 16:46:56 GMT 2023 , Edited by admin on Fri Dec 15 16:46:56 GMT 2023
|
PRIMARY | |||
|
CHEMBL2106747
Created by
admin on Fri Dec 15 16:46:56 GMT 2023 , Edited by admin on Fri Dec 15 16:46:56 GMT 2023
|
PRIMARY | |||
|
100000084534
Created by
admin on Fri Dec 15 16:46:56 GMT 2023 , Edited by admin on Fri Dec 15 16:46:56 GMT 2023
|
PRIMARY | |||
|
31041
Created by
admin on Fri Dec 15 16:46:56 GMT 2023 , Edited by admin on Fri Dec 15 16:46:56 GMT 2023
|
PRIMARY | |||
|
GAMFEXINE
Created by
admin on Fri Dec 15 16:46:56 GMT 2023 , Edited by admin on Fri Dec 15 16:46:56 GMT 2023
|
PRIMARY | |||
|
DTXSID50864033
Created by
admin on Fri Dec 15 16:46:56 GMT 2023 , Edited by admin on Fri Dec 15 16:46:56 GMT 2023
|
PRIMARY | |||
|
7273-99-6
Created by
admin on Fri Dec 15 16:46:56 GMT 2023 , Edited by admin on Fri Dec 15 16:46:56 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> RACEMATE | |||
|
ENANTIOMER -> RACEMATE | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |